To mark the 25th anniversary of a landmark framework in cancer research, Cell has published a special issue devoted to the biological processes that drive cancer and their therapeutic implications.
Read more
El tratamiento con Zongertinib ya demostró sus beneficios como terapia de segunda línea en este tipo de cáncer
Read more
20% of breast cancer diagnoses are actually precancerous lesions. As it is not yet possible to know which ones will progress to cancer, the vast majority are treated as if they were already cancerous
Read more
After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...
Read more
IDT has expanded its Coralville manufacturing footprint, boosting synthesis capacity by threefold, to meet the rapidly growing demand for MRD and NGS-based oncology research workflows
Read more
Un investigador de la UPM participa en un estudio que indica que el ejercicio regular podría ayudar a proteger la fertilidad frente a los efectos del cisplatino, un medicamento usado en quimioterapia...
Read more
Un estudio del Instituto de Neurociencias (CSIC-UMH) identifica el gen Prrx1 como regulador del potencial metastásico en el cáncer de mama
Read more
INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), today announced completion of patient recruitment in its first-in-human st...
Read more
Investigadores del Cancer Center Clínica Universidad de Navarra (CCUN), en colaboración con un grupo del Hospital Clínic de Barcelona, han desarrollado una estrategia de vacunación que permite pot...
Read more
Investigators from VHIO, which is part of the Vall Hebron Campus, publish the first study to address the impact of the exposome on early-onset colorectal cancer through epigenetic signatures.
Read more
La creación de una estrategia de cribado personalizada permitirá establecer los pasos a seguir en cada persona según su nivel de riesgo concreto.
Read more
El proyecto, liderado por INCLIVA, el Hospital del Mar Research Institute y el Vall d’Hebron Instituto de Oncología, ha desarrollado modelos basados en inteligencia artificial y en el uso de la bio...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
